Chevallard Daniel R.
LENZ Therapeutics, Inc. · Chief Financial Officer
Chevallard Daniel R. is listed in public filings as officer: Chief Financial Officer. This Chevallard Daniel R. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include LENZ Therapeutics, Inc. (LENZ). Investors use Chevallard Daniel R.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $110k12.9k shares | BuyMar 27, 2026 | $64.3K7.5k shares | $8.57 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.3M84.2k shares | Grant / ExerciseJan 2, 2026 | $1.3M84.2k shares | $16.00 | -- | |
| --14k shares | Grant / ExerciseJan 2, 2026 | Disclosure amount unavailable14k shares | -- | -- | |
| $73k3.2k shares | BuyNov 7, 2025 | $45420 shares | $22.71 | -- | |
| $123k5.4k shares | BuyNov 7, 2025 | $49.6K2.2k shares | $22.76 | -- | |
| $1.9M70.4k shares | Grant / ExerciseJan 9, 2025 | $1.9M70.4k shares | $26.34 | -- |